O Desafio de Incorporar Tecnologias de Alto Custo: Uma Análise dos Inibidores de PCSK9 / The Challenge of Incorporating High-Cost Technologies: An Analysis of PCSK9 Inhibitors
Arq. bras. cardiol
; 117(5): 997-998, nov. 2021.
Article
in En, Pt
| LILACS
| ID: biblio-1350006
Responsible library:
BR1.1
Key words
Análise de Custo-Benefício; Aterosclerose; Atherosclerosis; Avaliação de Tecnologia Biomédica; Cost-Bebefit Analysis; Gastos em Saúde; Health Expenditures; Proprotein Convertase/therapeutic use; Pró-Proteína Convertase 9/uso terapêutico; Sistema Único de Saúde (SUS); Technology Assessment, Biomedical; Unified Health System
Full text:
1
Collection:
01-internacional
Database:
LILACS
Main subject:
Proprotein Convertase 9
Type of study:
Health_economic_evaluation
/
Health_technology_assessment
Limits:
Humans
Language:
En
/
Pt
Journal:
Arq. bras. cardiol
Journal subject:
CARDIOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
Brazil